Sexual Arousal Disorder Clinical Trial
| Verified date | February 2011 |
| Source | Palatin Technologies |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Food and Drug Administration |
| Study type | Interventional |
This 8 week at home study is designed to explore efficacy endpoints and evaluate the safety of intranasal Bremelanotide in women with Female Sexual Arousal Disorder. Efficacy will be assessed vs. a parallel placebo group.
| Status | Completed |
| Enrollment | 0 |
| Est. completion date | May 2007 |
| Est. primary completion date | May 2007 |
| Accepts healthy volunteers | |
| Gender | Female |
| Age group | 21 Years to 70 Years |
| Eligibility |
Inclusion Criteria: - Post menopausal and in general good health - In a stable relationship with a male partner for at least 6 months - Willing to attempt sexual activity once a week with your partner |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind
| Country | Name | City | State |
|---|---|---|---|
| United States | South Florida Medical Research | Aventura | Florida |
| United States | Center for Sexual Medicine at Sheppard Pratt | Baltimore | Maryland |
| United States | The Ohio State University | Columbus | Ohio |
| United States | Downtown Women's Health Care | Denver | Colorado |
| United States | Northeast Indiana Research | Fort Wayne | Indiana |
| United States | Clinical Study Center | Ft. Myers | Florida |
| United States | Advanced Biomedical Research, Inc | Hackensack | New Jersey |
| United States | Accelovance | Houston | Texas |
| United States | Medical Affiliated Research Center | Huntsville | Alabama |
| United States | University of California, Department of Family and Preventative Medicine | LaJolla | California |
| United States | Medford Women's Clinic, LLP | Medford | Oregon |
| United States | Coastal Connecticut Research | New London | Connecticut |
| United States | Clinical Trials Research Services, LLC | Pittsburgh | Pennsylvania |
| United States | The Center for Female Sexuality | Purchase | New York |
| United States | Wake Research Associates, LLC | Raleigh | North Carolina |
| United States | Women's Clinical Research Center | Seattle | Washington |
| United States | Quality of Life Medical & Research Center, LLC | Tucson | Arizona |
| United States | Center For Marital and Sexual Health of South Florida | West Palm Beach | Florida |
| United States | Advanced Clinical Therapies, Inc. | West Reading | Pennsylvania |
| United States | Lyndhurst Gynecologic Associates | Winston-Salem | North Carolina |
| Lead Sponsor | Collaborator |
|---|---|
| Palatin Technologies | King Pharmaceuticals is now a wholly owned subsidiary of Pfizer |
United States,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05039775 -
Clitoral Therapy Device in Alleviating Sexual Dysfunction After Genital Mutilation.
|
N/A | |
| Completed |
NCT02570282 -
Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder
|
Phase 2 | |
| Recruiting |
NCT05765487 -
Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%
|
Phase 1 | |
| Not yet recruiting |
NCT02059798 -
Urinary and Sexual Function Before and After Surgical Decompression of Cervical Myelopathy
|
N/A | |
| Completed |
NCT04566783 -
Identification of Etiopathological and Clinical Factors in Persistent Genital Arousal Disorder
|
||
| Completed |
NCT03592121 -
Study to Investigate the Effect of AB-101 in Breast Cancer Survivors
|
Early Phase 1 | |
| Completed |
NCT00746967 -
An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder
|
Phase 2 | |
| Completed |
NCT03720743 -
Effect of Biodanza on Desire, Excitation and Sexual Inhibition
|
N/A | |
| Completed |
NCT04673708 -
H - Test Usage in Identification of Sexual Orientation Among People.
|
N/A |